Tania Small

Bio:

Dr. Tania Small is an accomplished physician and global healthcare executive with a deep passion for transforming patient outcomes and driving equitable access to innovative medicines. As the Head of Global Medical Affairs at Bristol Myers Squibb, she leads a dynamic, multidisciplinary team focused on delivering next-generation therapies that address unmet needs in oncology, hematology, immunology, and neuroscience. Under her leadership, the organization has achieved groundbreaking progress, including advances that have redefined standards of care for cancer and rare diseases.

Dr. Small began her career as a pediatric hematologist-oncologist, where she provided compassionate, cutting-edge care to children and families navigating serious illnesses. Witnessing both the resilience of families and the urgent need for better therapies, she was motivated to scale her impact and transitioned into drug development. In this capacity, she has championed innovation at the intersection of science, digital health, and patient advocacy. She has worked closely with regulatory bodies such as the FDA, as well as patient advocacy groups, academic institutions, and public-private partnerships, ensuring that the voices of patients and healthcare providers inform every step of the drug development process.

Her unwavering vision is to shape a future where healthcare is innovative, inclusive, and rooted in the needs of patients. Beyond her executive role, Dr. Small is a thought leader and advocate for advancing inclusivity in clinical research and healthcare delivery. She is a board member of the   Accreditation Council for Medical Affairs (ACMA), a member of multiple global medical organizations, and a sought-after speaker at conferences and podcasts. Her mission is clear: to revolutionize the experience and outcomes of individuals living with serious diseases through patient-driven science.

Dr. Small’s dedication to service extends to her philanthropic efforts, where she has raised millions of dollars for non-profits focused on cancer and other serious diseases. Her proven record of fostering collaboration, driving innovation, and achieving bold results reflects her commitment to shaping the future of health sciences through transformative leadership, patient empowerment, and groundbreaking discoveries. Above all, she believes in a world where science, compassion, and advocacy converge to create lasting impact.